The Clorox Company
NYSE:CLXHousehold & Personal Products
-$2.54 today
- Market cap
- $13.13B
- Beta
- 0.55
- P/E (TTM)
- 15.2
- EPS (TTM)
- $6.23
- Dividend yield
- 5.22%
Volume 2.16M
Average 2.84M
CLX Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
The Clorox CompanyNYSE: CLX
Other Non-Cash Items · Q1 FY2027 · quarter ended Sep 2026
Other non-cash items grows, but more slowly than its trailing trend
Q1 FY2027 other non-cash items of $131M (cash outflow) rose 991.7% year over year, behind the +1724.2% change in trailing-twelve-month other non-cash items. Sequentially, it rose 111.3% from the prior quarter.
Context
- Other non-cash items amounted to 7.2% of revenue in FY2026, up 6.0 pp from a year earlier.
- Other non-cash items increased in 0 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +991.7% toward the trailing-twelve-month pace of +1724.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2026
- (483M) USD
- Year-over-year change
- -661.6%
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | (483M) | -661.6% |
| FY2025 | 2025-06-30 | 86M | -80.2% |
| FY2024 | 2024-06-30 | 435M | -9.9% |
| FY2023 | 2023-06-30 | 483M | +263.2% |
| FY2022 | 2022-06-30 | 133M | — |
Other Non-Cash Items vs competitors
How CLX compares with its peers on the latest reported figures
- Peers report in different currencies, so other non-cash items is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +1724.2% is the 2nd highest of 9, against a peer median of +80.3%.
- Other non-cash items amounts to 8.4% of revenue for CLX, versus a peer median of 2.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | €2.84B EUR | -235.3% | +20.5% | 5.6% | |
| LTM Sep 2026 | $1.16B USD | +2376.6% | +20.4% | 5.5% | |
| LTM Sep 2026 | $939M USD | +496.2% | +90.6% | 6.0% | |
| LTM Jun 2026 | $770M USD | +77.8% | — | 4.6% | |
| LTM Sep 2026 | $602M USD | +1724.2% | — | 8.4% | |
| LTM Sep 2026 | $561M USD | -87.2% | — | 0.6% | |
| LTM Sep 2026 | $74.8M USD | +17.2% | -32.1% | 1.2% | |
| LTM Dec 2025 | $72.54M USD | — | +332.1% | — | |
| LTM Mar 2026 | $48.7M USD | +318.4% | — | 2.3% | |
| LTM Jun 2026 | $32M USD | +82.9% | -44.6% | 1.1% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding CLX) | — | +80.3% | +20.4% | 2.3% | |
Competitors are the stored peer set for CLX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Net Income | 471M | 161M | 292M | 824M | 601M |
| Depreciation & Amortization | 224M | 236M | 235M | 219M | 247M |
| Deferred Income Tax | 5M | (149M) | (100M) | (18M) | 81M |
| Stock-Based Compensation | 52M | 73M | 74M | 81M | 48M |
| Change in Working Capital | (99M) | 354M | (241M) | (211M) | 118M |
| Accounts Receivables | (84M) | (13M) | (34M) | (145M) | 151M |
| Inventory | (18M) | 58M | 55M | 63M | (71M) |
| Accounts Payables | (47M) | 157M | (140M) | (124M) | 38M |
| Other Working Capital | 50M | 152M | (122M) | (5M) | 0 |
| Other Non-Cash Items | 133M | 483M | 435M | 86M | (483M) |
| Operating Cash Flow | 786M | 1.16B | 695M | 981M | 612M |
| Capital Expenditures | (251M) | (228M) | (212M) | (220M) | (207M) |
| Acquisitions (Net) | 0 | 0 | 17M | 128M | (2.1B) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 22M | 5M | 20M | (2M) | 10M |
| Investing Cash Flow | (229M) | (223M) | (175M) | (94M) | (2.3B) |
| Debt Repayment | (83M) | (188M) | (45M) | 0 | 2.57B |
| Common Stock Issued | 5M | 33M | 1M | 26M | (23M) |
| Common Stock Repurchased | (25M) | 0 | 0 | (332M) | (256M) |
| Dividends Paid | (571M) | (583M) | (595M) | (602M) | (602M) |
| Other Financing Activities | (15M) | (15M) | (16M) | (16M) | (16M) |
| Financing Cash Flow | (689M) | (753M) | (655M) | (924M) | 1.67B |
| Effect of Forex Changes | (6M) | 2M | (26M) | 2M | (2M) |
| Net Change in Cash | (138M) | 184M | (161M) | (35M) | (23M) |
| Free Cash Flow | 535M | 930M | 483M | 761M | 405M |
The Clorox Company
NYSE:CLX
Intrinsic Alpha fair value
Locked
Current Price
$108.39
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.